Humacyte (HUMA) Current Assets (2020 - 2026)

Humacyte (HUMA) has 7 years of Current Assets data on file, last reported at $63.6 million in Q1 2026.

• Current Assets for Q1 2026 came in at $63.6 million, down 13.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.6 million (down 13.71% YoY), and the FY2025 annual result was $67.8 million, up 41.66% from the prior year.
• Current Assets retreated to $63.6 million in Q1 2026 per HUMA's latest filing, from $67.8 million in the prior quarter.
• Over five years, Current Assets peaked at $209.3 million in Q1 2022 and troughed at $23.0 million in Q3 2024.
• A 5-year average of $103.2 million and a median of $96.1 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2024: Current Assets jumped 41610.87% in 2022, then tumbled 77.63% in 2024.
• A 5-year view of Current Assets shows it stood at $154.2 million in 2022, then tumbled by 46.0% to $83.3 million in 2023, then plunged by 42.53% to $47.9 million in 2024, then jumped by 41.66% to $67.8 million in 2025, then slipped by 6.19% to $63.6 million in 2026.
• Business Quant data shows HUMA's Current Assets at $63.6 million in Q1 2026, $67.8 million in Q4 2025, and $41.4 million in Q3 2025.